FIELD: medicine.
SUBSTANCE: the present innovation deals with methods and compositions for targeted supply of circulation -overlapping solid-phase thrombocytes-binding preparations for treating vascularized tumor or hyperplastic tissue. The solid-phase preparation covered except polystyrene with thrombocytes-binding preparation, such as Willebrand's factor, should be purposefully directed towards vascular net-target in vivo, where it binds and activates thrombocytes which, in their turn, bind and activate other thrombocytes. Variant of composition for inducing thrombogenesis in vivo and containing a solid-phase thrombocytes-binding preparation, except polystyrene, could be consisted of the first binding component and the second binding component, where the first binding component has got binding area for binding a solid-phase preparation with a ligand-receptor complex, and not with a ligand or receptor separately, as for the second binding component it has got binding area for thrombocytes. The innovation provides rapid formation of a dense thrombus that leads to overlapping the circulation in the desired area due to thrombocytic fixation towards the surface of a solid-phase preparation along with increasing its sizes and developing a multi-layer structure of activated thrombocytes as a dense matrix.
EFFECT: higher efficiency.
29 cl, 12 ex, 2 tbl
Title |
Year |
Author |
Number |
METHOD FOR OVERLAPPING CIRCULATION AND COMPOSITIONS FOR THEIR REALIZATION |
1999 |
- Stevart Mikaehl' Vill'Jam
- Person Roland Khenrik
- N'Judzhejm Antoin
|
RU2227752C2 |
ISOLATED GLYCOPROTEIN IB ALPHA POLYPEPTIDE OF HUMAN THROMBOCYTES, FUSED PROTEIN, DNA MOLECULE (VERSIONS), EXPRESSION VECTOR (VERSIONS), CELL (VERSIONS), POLYPEPTIDE EXPRESSION METHOD, FUSED PROTEIN EXPRESSION METHOD, PHARMACEUTICAL COMPOSITION (VERSIONS), METHOD OF INHIBITING BODING OF BLOOD CELLS TO BIOLOGICAL TISSUE IN BIOLOGICAL SYSTEM, METHOD OF INHIBITING BONDING OF PROTEIN TO BIOLOGICAL TISSUE IN BIOLOGICAL SYSTEM AND DISORDER TREATMENT METHOD |
2004 |
- Sho Grej
- Sako Dajann S.
- Kumar Ravindra
- Sjuj Tszin'
|
RU2403262C2 |
ANTI-THROMBOTIC AGENT AND HUMANIZED MONOCLONAL ANTIBODY RAISED AGAINST VON WILLEBRAND FACTOR |
1999 |
- Ko Man Sung
- Vaskes Maksimil'Jano
|
RU2223785C2 |
BISPECIFIC BINDING AGENTS FOR MODULATING BIOLOGICAL ACTIVITY |
2005 |
- Nilsen Ulrik B.
- Shoehberl' Birgit M.
|
RU2433831C2 |
COMPOSITIONS AND METHODS FOR INHIBITION OF STEM CELLS AND PRECURSOR CELLS BINDING WITH LYMPHOID TISSUE AND FOR REGENERATION OF GERMINAL CENTERS IN LYMPH TISSUES |
2011 |
|
RU2645069C2 |
THERAPEUTIC POLYPEPTIDES, HOMOLOGUES THEREOF, FRAGMENTS THEREOF AND APPLICATION THEREOF FOR MODULATION OF PLATELET-MEDIATED AGGREGATION |
2004 |
|
RU2524129C2 |
MODIFIERS OF GLYCOPROTEIN VI REPRESENTING NUCLEIC ACID |
2010 |
- Lehjzer Dzhuliana M.
- Raskoni Kristofer P.
- Bruks Duglas
- Zelenkofske Stiven L.
|
RU2571660C2 |
COMBINED THERAPY BY USING ANTIANGIOGENIC AGENTS AND TNF-ALPHA |
2002 |
- Grell' Mattias
- Gudman Sajmon
- Rjugg Kurtsio
|
RU2316337C2 |
METHOD FOR DETECTING ANTIPLATELET DRUG RESISTANCE IN PATIENTS WITH PROGRESSING CEREBRAL ATHEROSCLEROSIS |
2012 |
- Tanashjan Marineh Movsesovna
- Khamidova Zaira Magomedovna
- Ionova Viktorija Grigor'Evna
- Kostyreva Marina Vladimirovna
- Shabalina Alla Anatol'Evna
|
RU2478965C1 |
PEPTIDES OF DIRECTED ACTION OF VEGFR-1/NRP-1 |
2008 |
- Paskualini Renata
- Arap Vadikh
- Zhiurdanu Rikardu
- Kardo-Vila Marina
- Valente Ana Paula
- Seneviva Laserda De Al'Mejda Fabiu
|
RU2488592C2 |